Owlet (NYSE:OWLT – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its peers? We will compare Owlet to similar companies based on the strength of its analyst recommendations, institutional ownership, profitability, risk, valuation, dividends and earnings.
Institutional and Insider Ownership
72.6% of Owlet shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 36.2% of Owlet shares are held by insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Volatility & Risk
Owlet has a beta of 1.91, indicating that its share price is 91% more volatile than the S&P 500. Comparatively, Owlet’s peers have a beta of 5.47, indicating that their average share price is 447% more volatile than the S&P 500.
Profitability
This table compares Owlet and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Owlet | -8.61% | -601.24% | -15.96% |
| Owlet Competitors | -278.23% | -150.07% | -21.87% |
Valuation and Earnings
This table compares Owlet and its peers gross revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Owlet | $105.70 million | -$39.68 million | -5.41 |
| Owlet Competitors | $1.88 billion | $139.14 million | 10.75 |
Owlet’s peers have higher revenue and earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Owlet and its peers, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Owlet | 1 | 1 | 3 | 0 | 2.40 |
| Owlet Competitors | 4252 | 10480 | 18203 | 824 | 2.46 |
Owlet presently has a consensus target price of $15.00, indicating a potential upside of 269.91%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 25.49%. Given Owlet’s higher probable upside, equities research analysts clearly believe Owlet is more favorable than its peers.
Summary
Owlet peers beat Owlet on 7 of the 13 factors compared.
About Owlet
Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.
Receive News & Ratings for Owlet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owlet and related companies with MarketBeat.com's FREE daily email newsletter.
